A milestone for Indian medtech, NIT Rourkela-developed StopBleed receives regulatory approval: Our Bureau, Chennai Friday, ...

START appoints Dr Frank Smith as president of its XenoSTART preclinical research business unit: San Antonio, Texas Friday, February 27, 2026, 14:30 Hrs [IST] The START Center for ...

China NMPA accepts for priority review GSK’s NDA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Friday, February 27, 2026, 14: ...

Melodia Therapeutics AG, a clinical-stage biotechnology company based in Basel, Switzerland, announced that the United States Patent and Trademark Office (USPTO) has granted a key US patent covering a ...

Our Bureau, Chennai Friday, February 27, 2026, 12:15 Hrs [IST] ...

Our Bureau, Mumbai Friday, February 27, 2026, 13:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has ...

Novartis to invest $23 billion to build new radioligand therapy site in Denton: Basel Friday, February 27, 2026, 12:00 Hrs [IST] Novartis, a leading global innovative medicines co ...

RedHill Biopharma announces full sales and operational launch of Talicia in US: Raleigh, North Carolina Friday, February 27, 2026, 13:00 Hrs [IST] RedHill Biopharma Ltd., a specia ...

Lupin Ranks No. 1 globally in pharma; Tops all sectors in India in S&P ESG Assessment 2025: Our Bureau, Mumbai Friday, February 27, 2026, 11:30 Hrs [IST] Global pharma major Lupin ...

Asahi Kasei Pharma strengthens preclinical pipeline through exclusive global license pact with Alchemedicine for novel lead compounds: Tokyo Friday, February 27, 2026, 11:00 Hrs [ ...

Rahway, New Jersey Friday, February 27, 2026, 10:00 Hrs [IST] ...

GSK’s bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B: London, UK Friday, February 27, 2026, 09:00 Hrs [IST] ...